AlphaFold predicted structure
AGPAT2 · O15120

Mean pLDDT
91.1/ 100
Very high
278 residues
Confidence breakdown
- Very high(≥ 90)80%
- Confident(70–90)14%
- Low(50–70)1%
- Very low(< 50)5%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
1-acylglycerol-3-phosphate O-acyltransferase 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Diabetes with additional phenotypes suggestive of a monogenic aetiology
BIALLELIC, autosomal or pseudoautosomalFamilial diabetes
BIALLELIC, autosomal or pseudoautosomalInsulin resistance (including lipodystrophy)
BIALLELIC, autosomal or pseudoautosomalSevere insulin resistance and lipodystrophy syndromes
BIALLELIC, autosomal or pseudoautosomalRare genetic inflammatory skin disorders
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalNeonatal diabetes
BIALLELIC, autosomal or pseudoautosomal+3 more panels — install the extension to see the full list inline on any page.
Berardinelli-Seip congenital lipodystrophy
congenital generalized lipodystrophy
lipodystrophy
hereditary disease
monogenic diabetes
drug allergy
prostate cancer
Familial prostate cancer
mandibuloacral dysplasia
CIDEC-related familial partial lipodystrophy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
1-acyl-sn-glycerol-3-phosphate acyltransferase beta
Converts 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) into 1,2-diacyl-sn-glycerol-3-phosphate (phosphatidic acid or PA) by incorporating an acyl moiety at the sn-2 position of the glycerol backbone
AGPAT2 · O15120

Mean pLDDT
91.1/ 100
Very high
278 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0